Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Michael J. Rybak, Jennifer Le, Thomas P. Lodise, Donald P. Levine, John S. Bradley, Catherine Liu, Bruce A. Mueller, Manjunath P. Pai, Annie Wong-Beringer, John C. Rotschafer, Keith A. Rodvold, Holly D. Maples, Benjamin M. Lomaestro

Research output: Contribution to journalReview article

22 Scopus citations
Original languageEnglish (US)
Pages (from-to)835-863
Number of pages29
JournalAmerican Journal of Health-System Pharmacy
Issue number11
StatePublished - May 18 2020


  • nephrotoxicity
  • pharmacokinetics and pharmacodynamics
  • target attainment
  • vancomycin
  • vancomycin consensus guideline

PubMed: MeSH publication types

  • Journal Article

Cite this